SCHEMBL19080176

SCHEMBL19080176

c1ccc2c(c1)ccc1c2oc2cc(-c3ccc(-c4c5ccccc5c(-c5ccc6sc7ccccc7c6c5)c5ccccc45)cc3)c3ccccc3c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARSA P15289 1/20 0.35
CDC25A P30304 1/20 0.35
CDC25C P30307 1/20 0.35
CYP1A1 P04798 12/20 0.34
CYP1B1 Q16678 12/20 0.34
IKBKB O14920 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
CYP1A2 P05177 11/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
PRKDC P78527 2/20 0.33
ABCB1 P08183 2/20 0.33
ABCC1 P33527 2/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
PSMD14 O00487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19076911 0.89 ESR2 (0.35) ESR1ESR2ALDH1A1HPGDTDP1
SCHEMBL19081714 0.86 CYP1A1 (0.36) CYP1A1CYP1B1IKBKBESR1ESR2
SCHEMBL19076585 0.86 ESR2 (0.33) ESR1ESR2ALDH1A1HPGDMAPT
SCHEMBL19076717 0.86 S1PR5 (0.34) CYP1A1CYP1B1ESR1ESR2TDP1
SCHEMBL16067771 0.85 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL17931989 0.85 CYP1A1 (0.38) CYP1A1CYP1B1ESR2CYP1A2KDM4E
SCHEMBL19079985 0.85 CYP1A1 (0.48) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19079922 0.84 CYP1A1 (0.46) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19080180 0.84 CYP1A1 (0.36) CYP1A1CYP1B1IKBKBESR1ESR2
SCHEMBL19080175 0.84 GPR3 (0.33) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ARSA 4452/4885CDC25A 44/4885CDC25C 132/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ARSA 4452/4885CDC25A 44/4885CDC25C 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.